Last Updated:
The Jhunjhunwala household portfolio fell 13% to Rs 40,082.90 crore, in comparison with Rs 55,095.90 crore final quarter. Sensex and Nifty has declined by 8-9%
None of Jhunjhunwala’s prime 5 inventory holdings have generated constructive returns. (News18 Hindi)
After the dying of veteran inventory market investor Rakesh Jhunjhunwala, the Jhunjhunwala household’s inventory portfolio is now managed by his spouse, Rekha Jhunjhunwala. The current market downturn has impacted the household’s holdings.
While the Sensex and Nifty have skilled declines of 8-9 per cent because the finish of the September quarter, the Jhunjhunwala household portfolio has witnessed a extra vital drop of 13 per cent.
As of Tuesday night, the portfolio was valued at Rs 40,082.90 crores, down from Rs 55,095.90 crores on the finish of the earlier quarter.
None of Jhunjhunwala’s prime 5 inventory holdings have generated constructive returns. The household’s most substantial investments lie in Titan, Concord Biotech, Star Health and Allied Insurance, Tata Motors, and Metro Brands. Shares of all these firms have skilled declines starting from 6 to 24 per cent.
Titan
Jhunjhunwala has a 5.1% or ₹14,741 crore stake in Titan Company Limited. This inventory has fallen by 15.80% since September 30. The most important cause for this decline is believed to be the corporate’s weak second quarter (Q2) outcomes. Titan’s jewelry phase margins had been decrease than anticipated and the corporate minimize margin steerage by 100 foundation factors for FY25. Brokerages like Goldman Sachs and Jefferies imagine that customized obligation cuts boosted jewelry progress, however had a unfavourable impression on reported margins.
Tata Motors
Shares of Tata Motors, through which the Jhunjhunwala household has a 1.3% stake, have fallen by 20% since 30 September. The firm’s British arm, Jaguar Land Rover (JLR), maintained EBIT margin steerage for FY25 at 8.5% however lowered free money movement (FCF) steerage to 1.3 billion kilos from 1.8 billion kilos. This is believed to be on account of larger capex (capital expenditure). Incred Equities stated that regardless of higher product combine, weak common promoting value (ASP), declining gross margins and rising advertising and marketing bills are considerations.
Star Health and Allied Insurance
Star Health shares have fallen by 24%. Its Q2 outcomes noticed a 410 foundation level improve in declare ratio. This improve was on account of a protracted monsoon, elevated circumstances of vital diseases, and elevated share in group enterprise. Analysts imagine that the corporate’s enchancment in scale will cut back the expense ratio, however the impression on the loss ratio will rely on pricing and product combine. MOFSL has retained a “purchase” score with a goal of Rs 630.
Metro Brands
Metro Brands shares fell 13%. The final six quarters have been fairly eventful for the corporate. Gross margins had been impacted on account of FILA’s stock liquidation in Q2FY25. However, the corporate has accelerated the tempo of retailer additions and goals to open 100 new shops in FY25. The firm’s income per retailer seems to be stabilising, however Q4FY25 will likely be a key check for its efficiency. Analysts have instructed a goal of Rs 1,175.
